Adhesion, proliferation and viability of human umbilical vein endothelial cells cultured on the surface of biodegradable non-woven matrices modified with RGD peptides
https://doi.org/10.15825/1995-1191-2019-1-142-152
Abstract
Tissue engineering is a promising area for the production of small-diameter vascular grafts. In recent years, a number of strategies have been developed to make the polymer surfaces of vascular prostheses capable to selectively adhesion of endothelial cells. The arginine–glycine–aspartic acid (RGD) sequence (a cell adhesion site that is present on many extracellular matrix proteins) is the promising target for modification. The efficiency of attachment of endothelial cells can be influenced both by the structure of RGD peptide and the extent of linker group.
Aim: to determine the optimal method for modification of non-woven matrices of polyhydroxybutyrate/ valerate and polycaprolactone (PHBV/PCL) by RGD-peptides leading to the increasing of adhesion, viability and proliferation of endothelial cells.
Materials and methods. Electrospinning was used to produce 4 mm diameter tubular polymer matrices from PHBV/PCL. Modification of surface of polymer scaffolds was performed using 4,7,10-trioxa-1,13-tridekandiamin, hexamethylenediamine, glutaraldehyde, ninhydrin, ascorbic acid, a cyclic peptide c [RGDFK], RGDK, AhRGD. The quality of modification was assessed by ninhydrin test and determination of arginine-containing peptide. The structure of the surface of matrices before and after modification was studied by scanning electron microscopy. Adhesion, viability and proliferation of Human umbilical vein (HUVEC) endothelial cells cultured for 7 days on the surface of matrices in the presence of RGD and without one were examined using fluorescence and laser scanning microscopy after the cells were pre-stained with fluorescent nuclear dyes (ethidium bromide and Hoechst 33342), and also by special kits for proliferation assessment (Click-iTTM Plus EdU Alexa FluorTM 488 Imaging Kit).
Results. RGD peptides bound to the matrix surface via a long linker (4,7,10-trioxa-1,13-tridecanediamine) were characterized by the increased bioavailability and activity. High level of cell adhesion, viability and proliferation were noted on the surface of RGDK and c[RGDFK] modified matrices, whereas their paired analogues with a short linker (hexamethylenediamine) showed low results of cellular viability even against satisfactory cell adhesion.
Discussion. Non-woven matrices based on PHBV/PCL and modified using 4,7,10-trioxa-1,13-tridecanediamine showed better results in case of adhesion of HUVEC and subsequent preservation of cell viability and proliferation. RGD-containing peptides of RGDK and c [RGDFK] were more tropic to endothelial cell receptors.
About the Authors
L. V. AntonovaRussian Federation
6, Sosnovy Boulevard, Kemerovo, 650002.
Теl. (3842) 64-38-02.
V. N. Silnikov
Russian Federation
Novosibirsk
M. Yu. Khanova
Russian Federation
Kemerovo
L. S. Koroleva
Russian Federation
Novosibirsk
I. Yu. Serpokrilova
Russian Federation
Novosibirsk
E. A. Velikanova
Russian Federation
Kemerovo
V. G. Matveeva
Russian Federation
Kemerovo
E. A. Senokosova
Russian Federation
Kemerovo
A. V. Mironov
Russian Federation
Kemerovo
E. O. Krivkina
Russian Federation
Kemerovo
Yu. A. Kudryavtseva
Russian Federation
Kemerovo
L. S. Barbarash
Russian Federation
Kemerovo
References
1. Taggart DP. Current status of arterial grafts for coronary artery bypass grafting. Ann Cardiothorac Surg. 2013; 2 (4): 427–430.
2. Ren X, Feng Y, Guo J, Wang K, Li Q, Yang J et al. Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications. Chem Soc Rev. 2015; 44 (15): 5680–5742.
3. Wang F, Li Y, Shen Y, Wang A, Wang S, Xie T. The functions and applications of RGD in tumor therapy and tissue engineering. Int J Mol Sci. 2013; 14 (7): 13447– 13462.
4. Harburger DS, Calderwood DA. Integrinsignalling at a glance. J Cell Sci. 2009; (122): 159–163.
5. Gabriel M, van NieuwAmerongen GP, van Hinsbergh VW, Amerongen AV, Zentner A. Direct grafting of RGD-motif-containing peptide on the surface of polycaprolactone films. J Biomater Sci Polym Ed. 2006; 17 (5): 567–577.
6. Gabriel M, Nazmi K, Dahm M, Zentner A, Vahl CF, Strand D. Covalent RGD modification of the inner pore surface of polycaprolactone scaffolds. J Biomater Sci Polym Ed. 2012; 23 (7): 941–953.
7. Hersel U, Dahmen C, Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials. 2003; 24 (24): 4385–4415.
8. Houseman BT, Mrksich M. The microenvironment of immobilized Arg-Gly-Asp peptides is an important determinant of cell adhesion. Biomaterials. 2001; 22 (9): 943–955.
9. Lee JW, Park YJ, Lee SJ, Lee SK, Lee KY. The effect of spacer arm length of an adhesion ligand coupled to an alginate gel on the control of fibroblast phenotype. Biomaterials. 2010; 31: 5545–5551.
10. Santiago LY, Nowak RW, Rubin JP, Marra KG. Peptidesurface modification of poly(caprolactone) with lamininderived sequences for adipose-derived stem cell applications. Biomaterials. 2006; 27: 2962–2969.
11. Lin HB, Sun W, Mosher DF, Garciaecheverria C, Schaufelberger K, Lelkes PI, Cooper SL. Synthesis, surface, and celladhesion properties of polyurethanes containing covalently grafted RGD-peptides. J Biomed Mater Res. 1994; 28: 329–342.
12. Parniak MA, Lange G, Viswanatha T. Quantitative determination of monosubstituted guanidines: a comparative study of different procedures. J Biochem Biophys Methods. 1983; 7: 267–276.
13. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. Clin Invest. 1973; 52: 2745–2756.
Review
For citations:
Antonova L.V., Silnikov V.N., Khanova M.Yu., Koroleva L.S., Serpokrilova I.Yu., Velikanova E.A., Matveeva V.G., Senokosova E.A., Mironov A.V., Krivkina E.O., Kudryavtseva Yu.A., Barbarash L.S. Adhesion, proliferation and viability of human umbilical vein endothelial cells cultured on the surface of biodegradable non-woven matrices modified with RGD peptides. Russian Journal of Transplantology and Artificial Organs. 2019;21(1):142-152. (In Russ.) https://doi.org/10.15825/1995-1191-2019-1-142-152